Singapore markets open in 5 hours 31 minutes

Nautilus Biotechnology, Inc. (NAUT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8900+0.0300 (+1.05%)
As of 03:17PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 358.26M
Enterprise value 210.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.44
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.65

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 318.18%
S&P500 52-week change 326.16%
52-week high 34.6500
52-week low 32.2740
50-day moving average 32.6394
200-day moving average 32.8874

Share statistics

Avg vol (3-month) 375.42k
Avg vol (10-day) 357.63k
Shares outstanding 5125.27M
Implied shares outstanding 6125.27M
Float 841.48M
% held by insiders 133.60%
% held by institutions 150.14%
Shares short (30 Apr 2024) 41.12M
Short ratio (30 Apr 2024) 416.72
Short % of float (30 Apr 2024) 42.68%
Short % of shares outstanding (30 Apr 2024) 40.89%
Shares short (prior month 28 Mar 2024) 41.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-15.70%
Return on equity (ttm)-24.38%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -77.72M
Net income avi to common (ttm)-67.44M
Diluted EPS (ttm)-0.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)181.37M
Total cash per share (mrq)1.45
Total debt (mrq)33.62M
Total debt/equity (mrq)13.48%
Current ratio (mrq)20.09
Book value per share (mrq)1.99

Cash flow statement

Operating cash flow (ttm)-55.45M
Levered free cash flow (ttm)-33.61M